Lv3
222 积分 2024-02-29 加入
Tumor-Specific Activation of an EGFR-Targeting Probody Enhances Therapeutic Index
9天前
已完结
Colorectal cancer
21天前
已完结
Placental and Fetal Effects of Onartuzumab, a Met/HGF Signaling Antagonist, When Administered to Pregnant Cynomolgus Monkeys
28天前
已完结
New antitumor monoclonal antibody-vinca conjugates LY203725 and related compounds: design, preparation, and representative in vivo activity
1个月前
已完结
Izalontamab brengitecan, an EGFR and HER3 bispecific antibody–drug conjugate, versus chemotherapy in heavily pretreated recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 study in China
1个月前
已完结
Pharmaceutical strategies in the emerging era of antibody-based biotherapeutics for the treatment of cancers overexpressing MET receptor tyrosine kinase
2个月前
已完结
Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study
3个月前
已完结
Immunoaffinity Enrichment Lc–Ms/Ms Quantitation Ofcdh17 in Tissues
3个月前
已完结
A novel humanized anti-HER2 antibody conjugated with MMAE exerts potent anti-tumor activity
3个月前
已完结
Molecular Targeting of EGFR, BRAF, and HER2 Signaling in Colorectal Cancer: Contemporary Advances with Panitumumab, Encorafenib, and Tucatinib
3个月前
已完结
皖公网安备34019202002308
